Research professionals are encouraged to use the contact information on the "Our Team" page of this site to get in touch with members of the NCPC team, or email us at ncpc@northwestern.edu for more information about chemoprevention trials.
Information regarding previous publications and findings can be found in the "Completed Trials" section of our website.
Are you planning a
kidney transplant?
People who receive a kidney transplant must begin taking medications after their transplant surgery to help keep the body from “fighting off” the new kidney, but they also lower the body’s immune system as a side effect. This can make it harder for the body to fight off infections, including human papillomavirus (HPV). Because of this, men and women who have transplant surgery are at a higher risk of developing cancers that are caused by HPV, such as cervical, vulvar, vaginal, penile, throat, and anal cancers. Researchers believe that receiving the Gardasil vaccine before transplant surgery happens may protect transplant recipients from HPV and the cancers it causes.
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
Principal Investigator: Marc T. Goodman, Ph.D, M.P.H.
Cedars Sinai Medical Center
This study is no longer accepting patients. To learn more about this study, please visit
Additional Resources
How you can Help Medical Research
Study Brochure
University of Alabama at Birmingham
Research Opportunities
University of Alabama at Birmingham
Transplants and Vaccines - Fact Sheet
Transplante de riñón y prevención del cáncer
Study Brochure
Cedars-Sinai Medical Center
Study Brochure
University of California at San Francisco
Folleto de Estudio
Universidad de California San Francisco
Research Opportunities
University of California San Francisco
Oportunidades de Investigación
Universidad de California San Francisco
Research Opportunities
Cedars-Sinai Medical Center